Market Research Logo

Molecular Imaging Market: Increasing Application of Integrated PET-CT and PET-MR Devices to Drive Revenue Growth: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027

Molecular Imaging Market: Increasing Application of Integrated PET-CT and PET-MR Devices to Drive Revenue Growth: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027

In a recent publication titled “Molecular Imaging Market: Global Industry Analysis (2012 –2016) and Opportunity Assessment (2017 – 2027),” we have considered the weighted average pricing for different molecular imagingdevices. This has been done on the basis of information gathered from reliable secondarysources validated through marketplace discussions and private company databases. We have also observed that pricing values of molecular imaging devices have been counter validated with market experts through primary research along with regional variations in price levels. It is very necessary to note that this pricing analysis does not include margins analysis from the manufacturers end. Currency fluctuations have not been taken into account and the analysis is static in nature. It also rules out impact of extreme events in specific countries. Weighted averaging of high-end and low-end pricing has been done to rule out effect of extreme values and brand weightages. A demand-supply gap analysis has been performed involving both marketplace discussion and desk research to determine pricing premiums.

Report Structure

This report begins with the market definition, followed by definitions of the different molecular imaging devices. The market dynamics section includes Future Market Insights’ analysis on key trends, drivers, restraints, opportunities and macro-economic factors that are influencing the growth of the global molecular imaging market and key regulations for medical devices. Also, the pricing analysis of different products in the segment is mentioned for upcoming molecular imaging products. The report analyses the market on the basis of application and presents forecast by value for the next 10 years. The global molecular imaging market segments such as modality type, application, end-user and region, have been analysed on Basis Point Share (BPS) to understand the individual segment’s respective contributions to market growth. This detailed level of information is important for identifying various key trends in the global molecular imaging market.

At the end of the report, list of key players have been provided who are engaged in the market for global molecular imaging. This section is preferably designed to provide clients with an aim and detailed comparative assessment of key providers specific to the market segment in the global molecular imaging market and the potential players. In addition, this section includes company details, company overview, key developments and market strategies of the profiled key player active in the global molecular imaging market. Detailed profiles of molecular imaging devices manufacturers are also included in the scope of the report to evaluate their strategies in a bid to sustain in this competitive market.

Research Methodology

Macro-economic indicators such as molecular imaging market outlook, gross domestic product and others has been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers, while top-down approach has been used to counter-validate the reached numbers for molecular imaging Market numbers. The analysts of Future Market Insights have performed systematic exhaustive secondary research to analyse the required data points to arrive at the overall market numbers. Our analysts have developed questionnaires for each node in the value chain to extract the required market information through primary research interviews. While conducting interviews we have used distinguished essential resources. Data is validated by triangulation method, wherein secondary, primary and Future Market Insight’s analysis have contributed to the final data.


1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Molecular Imaging Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Regional Pricing Analysis by Product Type
3.4. Installed Base Analysis
4. North America Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
4.5.1. Positron Emission Tomography (PET)
4.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)
4.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
4.5.4. Single Photon Emission Computed Tomography (SPECT)
4.5.5. Magnetic Resonance Spectroscopy
4.5.6. Molecular Ultrasound Imaging
4.5.7. Software
4.5.7.1. On Premises Solutions
4.5.7.2. Cloud Based Solutions
4.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027
4.6.1. Positron Emission Tomography (PET)
4.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)
4.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
4.6.4. Single Photon Emission Computed Tomography (SPECT)
4.6.5. Magnetic Resonance Spectroscopy
4.6.6. Molecular Ultrasound Imaging
4.6.7. Software
4.6.7.1. On Premises Solutions
4.6.7.2. Cloud Based Solutions
4.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
4.7.1. Hospitals
4.7.1.1. 500+ Beds
4.7.1.2. 200-499 Beds
4.7.1.3. Less than 200 Beds
4.7.2. Ambulatory Surgical Centers
4.7.3. Diagnostic Imaging Centers
4.8. Market Size (US$ Mn) Forecast By Application, 2017–2027
4.8.1. Cardiology
4.8.2. Oncology
4.8.3. Gastrointestinal Disorders
4.8.4. Neurology Disorders
4.8.5. Others
4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.9.1. Cardiology
4.9.2. Oncology
4.9.3. Gastrointestinal Disorders
4.9.4. Neurology Disorders
4.9.5. Others
4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.10.1. Hospitals
4.10.1.1. 500+ Beds
4.10.1.2. 200-499 Beds
4.10.1.3. Less than 200 Beds
4.10.2. Ambulatory Surgical Centers
4.10.3. Diagnostic Imaging Centers
4.11. Drivers and Restraints: Impact Analysis
4.12. Market Attractiveness Analysis
4.12.1. By Country
4.12.2. By Modality
4.12.3. By Application
4.12.4. By End User
4.13. Key Representative Market Participants
4.14. Market Presence (Intensity Map)
5. Latin America Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
5.5.1. Positron Emission Tomography (PET)
5.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)
5.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
5.5.4. Single Photon Emission Computed Tomography (SPECT)
5.5.5. Magnetic Resonance Spectroscopy
5.5.6. Molecular Ultrasound Imaging
5.5.7. Software
5.5.7.1. On Premises Solutions
5.5.7.2. Cloud Based Solutions
5.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027
5.6.1. Positron Emission Tomography (PET)
5.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)
5.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
5.6.4. Single Photon Emission Computed Tomography (SPECT)
5.6.5. Magnetic Resonance Spectroscopy
5.6.6. Molecular Ultrasound Imaging
5.6.7. Software
5.6.7.1. On Premises Solutions
5.6.7.2. Cloud Based Solutions
5.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
5.7.1. Hospitals
5.7.1.1. 500+ Beds
5.7.1.2. 200-499 Beds
5.7.1.3. Less than 200 Beds
5.7.2. Ambulatory Surgical Centers
5.7.3. Diagnostic Imaging Centers
5.8. Market Size (US$ Mn) Forecast By Application, 2017–2027
5.8.1. Cardiology
5.8.2. Oncology
5.8.3. Gastrointestinal Disorders
5.8.4. Neurology Disorders
5.8.5. Others
5.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.9.1. Cardiology
5.9.2. Oncology
5.9.3. Gastrointestinal Disorders
5.9.4. Neurology Disorders
5.9.5. Others
5.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.10.1. Hospitals
5.10.1.1. 500+ Beds
5.10.1.2. 200-499 Beds
5.10.1.3. Less than 200 Beds
5.10.2. Ambulatory Surgical Centers
5.10.3. Diagnostic Imaging Centers
5.11. Drivers and Restraints: Impact Analysis
5.12. Market Attractiveness Analysis
5.12.1. By Country
5.12.2. By Modality
5.12.3. By Application
5.12.4. By End User
5.13. Key Representative Market Participants
5.14. Market Presence (Intensity Map)
6. Western Europe Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. Spain
6.3.5. U.K.
6.3.6. BENELUX
6.3.7. Nordic
6.3.8. Rest of Western Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Germany
6.4.2. Italy
6.4.3. France
6.4.4. Spain
6.4.5. U.K.
6.4.6. BENELUX
6.4.7. Nordic
6.4.8. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
6.5.1. Positron Emission Tomography (PET)
6.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)
6.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
6.5.4. Single Photon Emission Computed Tomography (SPECT)
6.5.5. Magnetic Resonance Spectroscopy
6.5.6. Molecular Ultrasound Imaging
6.5.7. Software
6.5.7.1. On Premises Solutions
6.5.7.2. Cloud Based Solutions
6.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027
6.6.1. Positron Emission Tomography (PET)
6.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)
6.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
6.6.4. Single Photon Emission Computed Tomography (SPECT)
6.6.5. Magnetic Resonance Spectroscopy
6.6.6. Molecular Ultrasound Imaging
6.6.7. Software
6.6.7.1. On Premises Solutions
6.6.7.2. Cloud Based Solutions
6.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
6.7.1. Hospitals
6.7.1.1. 500+ Beds
6.7.1.2. 200-499 Beds
6.7.1.3. Less than 200 Beds
6.7.2. Ambulatory Surgical Centers
6.7.3. Diagnostic Imaging Centers
6.8. Market Size (US$ Mn) Forecast By Application, 2017–2027
6.8.1. Cardiology
6.8.2. Oncology
6.8.3. Gastrointestinal Disorders
6.8.4. Neurology Disorders
6.8.5. Others
6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.9.1. Cardiology
6.9.2. Oncology
6.9.3. Gastrointestinal Disorders
6.9.4. Neurology Disorders
6.9.5. Others
6.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.10.1. Hospitals
6.10.1.1. 500+ Beds
6.10.1.2. 200-499 Beds
6.10.1.3. Less than 200 Beds
6.10.2. Ambulatory Surgical Centers
6.10.3. Diagnostic Imaging Centers
6.11. Drivers and Restraints: Impact Analysis
6.12. Market Attractiveness Analysis
6.12.1. By Country
6.12.2. By Modality
6.12.3. By Application
6.12.4. By End User
6.13. Key Representative Market Participants
6.14. Market Presence (Intensity Map)
7. Eastern Europe Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
7.5.1. Positron Emission Tomography (PET)
7.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)
7.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
7.5.4. Single Photon Emission Computed Tomography (SPECT)
7.5.5. Magnetic Resonance Spectroscopy
7.5.6. Molecular Ultrasound Imaging
7.5.7. Software
7.5.7.1. On Premises Solutions
7.5.7.2. Cloud Based Solutions
7.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027
7.6.1. Positron Emission Tomography (PET)
7.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)
7.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
7.6.4. Single Photon Emission Computed Tomography (SPECT)
7.6.5. Magnetic Resonance Spectroscopy
7.6.6. Molecular Ultrasound Imaging
7.6.7. Software
7.6.7.1. On Premises Solutions
7.6.7.2. Cloud Based Solutions
7.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
7.7.1. Hospitals
7.7.1.1. 500+ Beds
7.7.1.2. 200-499 Beds
7.7.1.3. Less than 200 Beds
7.7.2. Ambulatory Surgical Centers
7.7.3. Diagnostic Imaging Centers
7.8. Market Size (US$ Mn) Forecast By Application, 2017–2027
7.8.1. Cardiology
7.8.2. Oncology
7.8.3. Gastrointestinal Disorders
7.8.4. Neurology Disorders
7.8.5. Others
7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.9.1. Cardiology
7.9.2. Oncology
7.9.3. Gastrointestinal Disorders
7.9.4. Neurology Disorders
7.9.5. Others
7.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.10.1. Hospitals
7.10.1.1. 500+ Beds
7.10.1.2. 200-499 Beds
7.10.1.3. Less than 200 Beds
7.10.2. Ambulatory Surgical Centers
7.10.3. Diagnostic Imaging Centers
7.11. Drivers and Restraints: Impact Analysis
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Modality
7.12.3. By Application
7.12.4. By End User
7.13. Drivers and Restraints: Impact Analysis
7.14. Market Attractiveness Analysis
7.14.1. By Country
7.14.2. By Modality
7.14.3. By End User
7.15. Key Representative Market Participants
7.16. Market Presence (Intensity Map)
8. Asia Pacific excluding Japan Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of APEJ
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of APEJ
8.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
8.5.1. Positron Emission Tomography (PET)
8.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)
8.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
8.5.4. Single Photon Emission Computed Tomography (SPECT)
8.5.5. Magnetic Resonance Spectroscopy
8.5.6. Molecular Ultrasound Imaging
8.5.7. Software
8.5.7.1. On Premises Solutions
8.5.7.2. Cloud Based Solutions
8.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027
8.6.1. Positron Emission Tomography (PET)
8.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)
8.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
8.6.4. Single Photon Emission Computed Tomography (SPECT)
8.6.5. Magnetic Resonance Spectroscopy
8.6.6. Molecular Ultrasound Imaging
8.6.7. Software
8.6.7.1. On Premises Solutions
8.6.7.2. Cloud Based Solutions
8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
8.7.1. Hospitals
8.7.1.1. 500+ Beds
8.7.1.2. 200-499 Beds
8.7.1.3. Less than 200 Beds
8.7.2. Ambulatory Surgical Centers
8.7.3. Diagnostic Imaging Centers
8.8. Market Size (US$ Mn) Forecast By Application, 2017–2027
8.8.1. Cardiology
8.8.2. Oncology
8.8.3. Gastrointestinal Disorders
8.8.4. Neurology Disorders
8.8.5. Others
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.9.1. Cardiology
8.9.2. Oncology
8.9.3. Gastrointestinal Disorders
8.9.4. Neurology Disorders
8.9.5. Others
8.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.10.1. Hospitals
8.10.1.1. 500+ Beds
8.10.1.2. 200-499 Beds
8.10.1.3. Less than 200 Beds
8.10.2. Ambulatory Surgical Centers
8.10.3. Diagnostic Imaging Centers
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Modality
8.12.3. By Application
8.12.4. By End User
8.13. Key Representative Market Participants
8.14. Market Presence (Intensity Map)
9. Japan Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
9.3.1. Positron Emission Tomography (PET)
9.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)
9.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
9.3.4. Single Photon Emission Computed Tomography (SPECT)
9.3.5. Magnetic Resonance Spectroscopy
9.3.6. Molecular Ultrasound Imaging
9.3.7. Software
9.3.7.1. On Premises Solutions
9.3.7.2. Cloud Based Solutions
9.4. Market Size (US$ Mn) Forecast By Modality, 2017–2027
9.4.1. Positron Emission Tomography (PET)
9.4.2. Positron Emission Tomography- Computed Tomography (PET-CT)
9.4.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
9.4.4. Single Photon Emission Computed Tomography (SPECT)
9.4.5. Magnetic Resonance Spectroscopy
9.4.6. Molecular Ultrasound Imaging
9.4.7. Software
9.4.7.1. On Premises Solutions
9.4.7.2. Cloud Based Solutions
9.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
9.5.1. Hospitals
9.5.1.1. 500+ Beds
9.5.1.2. 200-499 Beds
9.5.1.3. Less than 200 Beds
9.5.2. Ambulatory Surgical Centers
9.5.3. Diagnostic Imaging Centers
9.6. Market Size (US$ Mn) Forecast By Application, 2017–2027
9.6.1. Cardiology
9.6.2. Oncology
9.6.3. Gastrointestinal Disorders
9.6.4. Neurology Disorders
9.6.5. Others
9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
9.7.1. Cardiology
9.7.2. Oncology
9.7.3. Gastrointestinal Disorders
9.7.4. Neurology Disorders
9.7.5. Others
9.8. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.8.1. Hospitals
9.8.1.1. 500+ Beds
9.8.1.2. 200-499 Beds
9.8.1.3. Less than 200 Beds
9.8.2. Ambulatory Surgical Centers
9.8.3. Diagnostic Imaging Centers
9.9. Drivers and Restraints: Impact Analysis
9.10. Market Attractiveness Analysis
9.10.1. By Modality
9.10.2. By Application
9.10.3. By End User
9.11. Key Representative Market Participants
9.12. Market Presence (Intensity Map)
10. Middle East & Africa Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of MEA
10.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
10.5.1. Positron Emission Tomography (PET)
10.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)
10.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
10.5.4. Single Photon Emission Computed Tomography (SPECT)
10.5.5. Magnetic Resonance Spectroscopy
10.5.6. Molecular Ultrasound Imaging
10.5.7. Software
10.5.7.1. On Premises Solutions
10.5.7.2. Cloud Based Solutions
10.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027
10.6.1. Positron Emission Tomography (PET)
10.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)
10.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
10.6.4. Single Photon Emission Computed Tomography (SPECT)
10.6.5. Magnetic Resonance Spectroscopy
10.6.6. Molecular Ultrasound Imaging
10.6.7. Software
10.6.7.1. On Premises Solutions
10.6.7.2. Cloud Based Solutions
10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
10.7.1. Hospitals
10.7.1.1. 500+ Beds
10.7.1.2. 200-499 Beds
10.7.1.3. Less than 200 Beds
10.7.2. Ambulatory Surgical Centers
10.7.3. Diagnostic Imaging Centers
10.8. Market Size (US$ Mn) Forecast By Application, 2017–2027
10.8.1. Cardiology
10.8.2. Oncology
10.8.3. Gastrointestinal Disorders
10.8.4. Neurology Disorders
10.8.5. Others
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
10.9.1. Cardiology
10.9.2. Oncology
10.9.3. Gastrointestinal Disorders
10.9.4. Neurology Disorders
10.9.5. Others
10.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
10.10.1. Hospitals
10.10.1.1. 500+ Beds
10.10.1.2. 200-499 Beds
10.10.1.3. Less than 200 Beds
10.10.2. Ambulatory Surgical Centers
10.10.3. Diagnostic Imaging Centers
10.11. Drivers and Restraints: Impact Analysis
10.12. Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Modality
10.12.3. By Application
10.12.4. By End User
10.13. Key Representative Market Participants
10.14. Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Market Structure
13.2. Market Share Analysis
13.3. Competition Dashboard
13.4. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.4.1. Hermes Medical Solutions
13.4.2. MIM Corporation
13.4.3. Bruker Corporation
13.4.4. GE Healthcare
13.4.5. Fujifilm Holdings Corp.
13.4.6. Siemens Healthcare
13.4.7. Koninklijke Philips N.V.
13.4.8. Toshiba Medical Systems Corporation
13.4.9. Hitachi Medical Corporation
13.4.10. Mediso kft.
13.4.11. Positron Corporation
13.4.12. ESAOTE S.P.A.
13.4.13. Carestream Health
13.4.14. Mirada Medical Limited
14. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Modality
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016
15.2.1. Positron Emission Tomography (PET)
15.2.2. Positron Emission Tomography- Computed Tomography (PET-CT)
15.2.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
15.2.4. Single Photon Emission Computed Tomography (SPECT)
15.2.5. Magnetic Resonance Spectroscopy
15.2.6. Molecular Ultrasound Imaging
15.2.7. Software
15.2.7.1. On Premises Solutions
15.2.7.2. Cloud Based Solutions
15.3. Market Size (US$ Mn) Forecast By Modality, 2017–2027
15.3.1. Positron Emission Tomography (PET)
15.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)
15.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
15.3.4. Single Photon Emission Computed Tomography (SPECT)
15.3.5. Magnetic Resonance Spectroscopy
15.3.6. Molecular Ultrasound Imaging
15.3.7. Software
15.3.7.1. On Premises Solutions
15.3.7.2. Cloud Based Solutions
15.4. Market Attractiveness Analysis By Modality
16. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Application
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
16.2.1. Cardiology
16.2.2. Oncology
16.2.3. Gastrointestinal Disorders
16.2.4. Neurology Disorders
16.2.5. Others
16.3. Market Size (US$ Mn) Forecast By Application, 2017–2027
16.3.1. Cardiology
16.3.2. Oncology
16.3.3. Gastrointestinal Disorders
16.3.4. Neurology Disorders
16.3.5. Others
16.4. Market Attractiveness Analysis By Application
17. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By End User
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
17.2.1. Hospitals
17.2.1.1. 500+ Beds
17.2.1.2. 200-499 Beds
17.2.1.3. Less than 200 Beds
17.2.2. Ambulatory Surgical Centers
17.2.3. Diagnostic Imaging Centers
17.3. Market Size (US$ Mn) Forecast By End User, 2017–2027
17.3.1. Hospitals
17.3.1.1. 500+ Beds
17.3.1.2. 200-499 Beds
17.3.1.3. Less than 200 Beds
17.3.2. Ambulatory Surgical Centers
17.3.3. Diagnostic Imaging Centers
17.4. Market Attractiveness Analysis By End User
18. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027
18.1. Market Size and Y-o-Y Growth
18.2. Absolute $ Opportunity
19. Research Methodology
List of Figures
Figure 01: North America Molecular Imaging Market Size Analysis, 2012–2016
Figure 02: North America Molecular Imaging Market Forecast, 2017–2027
Figure 03: U.S. Molecular Imaging Market Size Analysis, 2012–2016
Figure 04: U.S. Molecular Imaging Market Forecast, 2017–2027
Figure 05: Canada Molecular Imaging Market Size Analysis, 2012–2016
Figure 06: Canada Molecular Imaging Market Forecast, 2017–2027
Figure 07: North America Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 08: North America PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 09: North America PET Molecular Imaging Market Forecast, 2017–2027
Figure 10: North America PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 11: North America PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 12: North America PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 13: North America PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 14: North America SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 15: North America SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 16: North America Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 17: North America Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 18: North America Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 19: North America Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 20: North America Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 21: North America Molecular Imaging Software Market Forecast, 2017–2027
Figure 22: North America Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 23: North America Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 24: North America Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 25: North America Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 26: North America Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 27: North America Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 28: North America Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 29: North America Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 30: North America Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 31: North America Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 32: North America Other Molecular Imaging Market Forecast, 2017–2027
Figure 33: North America Molecular Imaging Market Attractiveness Analysis By Application, 2017–2027
Figure 34: North America Hospital Molecular Imaging Market Size Analysis, 2012–2016
Figure 35: North America Hospital Molecular Imaging Market Forecast, 2017–2027
Figure 36: North America Ambulatory Surgical Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 37: North America Ambulatory Surgical Center Molecular Imaging Market Forecast, 2017–2027
Figure 38: North America Diagnostics Imaging Center Molecular Imaging Market Size Analysis, 2012–2016
Figure 39: North America Diagnostics Imaging Center Molecular Imaging Market Forecast, 2017–2027
Figure 40: North America Molecular Imaging Market Attractiveness Analysis By End User, 2017–2027
Figure 41: Latin America Molecular Imaging Market Size Analysis, 2012–2016
Figure 42: Latin America Molecular Imaging Market Forecast, 2017–2027
Figure 43: Brazil Molecular Imaging Market Size Analysis, 2012–2016
Figure 44: Brazil Molecular Imaging Market Forecast, 2017–2027
Figure 45: Mexico Molecular Imaging Market Size Analysis, 2012–2016
Figure 46: Mexico Molecular Imaging Market Forecast, 2017–2027
Figure 47: Rest of Latin America Molecular Imaging Market Size Analysis, 2012–2016
Figure 48: Rest of Latin America Molecular Imaging Market Forecast, 2017–2027
Figure 49: Latin America Molecular Imaging Market Attractiveness Analysis By Country, 2017–2027
Figure 50: Latin America PET Molecular Imaging Market Size Analysis, 2012–2016
Figure 51: Latin America PET Molecular Imaging Market Forecast, 2017–2027
Figure 52: Latin America PET-CT Molecular Imaging Market Size Analysis, 2012–2016
Figure 53: Latin America PET-CT Molecular Imaging Market Forecast, 2017–2027
Figure 54: Latin America PET-MR Molecular Imaging Market Size Analysis, 2012–2016
Figure 55: Latin America PET-MR Molecular Imaging Market Forecast, 2017–2027
Figure 56: Latin America SPECT Molecular Imaging Market Size Analysis, 2012–2016
Figure 57: Latin America SPECT Molecular Imaging Market Forecast, 2017–2027
Figure 58: Latin America Magnetic Resonance Spectroscopy Molecular Imaging Market Size Analysis, 2012–2016
Figure 59: Latin America Magnetic Resonance Spectroscopy Molecular Imaging Market Forecast, 2017–2027
Figure 60: Latin America Molecular Ultrasound Imaging Molecular Imaging Market Size Analysis, 2012–2016
Figure 61: Latin America Molecular Ultrasound Imaging Molecular Imaging Market Forecast, 2017–2027
Figure 62: Latin America Molecular Imaging Software Market Size Analysis, 2012–2016
Figure 63: Latin America Molecular Imaging Software Market Forecast, 2017–2027
Figure 64: Latin America Molecular Imaging Market Attractiveness Analysis By Modality, 2017–2027
Figure 65: Latin America Cardiology Molecular Imaging Market Size Analysis, 2012–2016
Figure 66: Latin America Cardiology Molecular Imaging Market Forecast, 2017–2027
Figure 67: Latin America Oncology Molecular Imaging Market Size Analysis, 2012–2016
Figure 68: Latin America Oncology Molecular Imaging Market Forecast, 2017–2027
Figure 69: Latin America Gastrointestinal Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 70: Latin America Gastrointestinal Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 71: Latin America Neurology Disorders Molecular Imaging Market Size Analysis, 2012–2016
Figure 72: Latin America Neurology Disorders Molecular Imaging Market Forecast, 2017–2027
Figure 73: Latin America Other Molecular Imaging Market Size Analysis, 2012–2016
Figure 74: Latin America Other Molecular Imaging Market Forecast, 2017–2027
Figure 75: Latin America Molecular Imaging Market Attractiveness Analysis By App

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report